(Reuters) – China’s WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed sum.
(Reporting by Rajasik Mukherjee; Editing by Krishna Chandra Eluri)
